Kyverna Therapeutics, Inc. KYTX Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Kyverna Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kyverna Therapeutics, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kyverna Therapeutics, Inc.'s change in AP?
- Kyverna Therapeutics, Inc. (KYTX) reported change in AP of $6.28M in Q1 2026.
- How has Kyverna Therapeutics, Inc.'s change in AP changed year-over-year?
- Kyverna Therapeutics, Inc.'s change in AP increased by 65.8% year-over-year, from $3.78M to $6.28M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.